Clinical study of treatment of chronic hepatitis B with kurorinone combined with thymosin / 解放军医学杂志

ABSTRACT

Objective To evaluate the effects of kurorinone combined with thymosin on the treatment of chronic hepatitis B. Methods 178 patients with chronic hepatitis B were randomly divided into group A, B and C. 64 patients in group A received kurorinone combined with thymosin for 3 months. 58 patients in group B received kurorinone only, and 56 patients in group C received thymosin only. Results At the end of treatment, HBeAg and HBV DNA negative-transformed rates were respectively 51.8% and 53.6% in group A, but 32.7% and 34.6% in group B, 21.6% and 21.6% in group C, the differences were statistically significant (P